AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9345682 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulation of the cervical spine on the side of an enlarged cortical map
Number of subjects: 500
Study 9345682 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulation of the cervical spine on the side opposite an enlarged cortical map
Number of subjects: 500
Study 9345682 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulation of the cervical spine
Number of subjects: 500
Study 12085760 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate overdentures on 2 lower canines
Number of subjects: 74
Study 12085760 — intervention group
Group type: COMPARATOR
Intervention: Immediate complete dentures
Number of subjects: 74
Study 3296635 — intervention group
Group type: EXPERIMENTAL
Intervention: somatrem, 0.5 IU/kg body weight/week for 3‐14 months
Number of subjects: 62
Study 3296635 — intervention group
Group type: EXPERIMENTAL
Intervention: somatrem
Number of subjects: 62
Study 29886507 — intervention group
Group type: EXPERIMENTAL
Intervention: Ground kayak paddling (GKP) exercise
Number of subjects: 60
Study 29886507 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 27626492 — intervention group
Group type: EXPERIMENTAL
Intervention: High expression of PROX1 protein in IDH-mutant anaplastic astrocytomas and secondary glioblastomas
Number of subjects: 340
Study 27626492 — intervention group
Group type: COMPARATOR
Intervention: PROX1 protein in primary glioblastomas
Number of subjects: 340
Study 27626492 — intervention group
Group type: COMPARATOR
Intervention: Gene expression data from the Cancer Genome Atlas
Number of subjects: 340
Study 25024177 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MP)
Number of subjects: 48
Study 22867037 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose alcohol (0.4 g/kg)
Number of subjects: 182
Study 22867037 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 182
Study 22867037 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose alcohol (0.8 g/kg)
Number of subjects: 182
Study 20883542 — intervention group
Group type: EXPERIMENTAL
Intervention: Efalizumab-based regimen (daclizumab induction, 6-month course of tacrolimus, maintenance with efalizumab and mycophenolate mofetil)
Number of subjects: 12
Study 20883542 — intervention group
Group type: COMPARATOR
Intervention: Edmonton protocol (standard regimen)
Number of subjects: 12
Study 18512085 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical MRI at baseline and repeated after 3 months
Number of subjects: 178
Study 18512085 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical follow-ups after 3 and 12 months
Number of subjects: 178
Study 15823211 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted behavioral intervention including training of opinion leaders and dissemination of evidence-based guidelines
Number of subjects: 24
Study 15823211 — intervention group
Group type: COMPARATOR
Intervention: Standard in-service training activities
Number of subjects: 24
Study 12618532 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon‐α-2b (INF‐α) and ribavirin therapy
Number of subjects: 55
Study 12618532 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated subjects)
Number of subjects: 55
Study 10375932 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 laser treatment
Number of subjects: 2046
Study 10375932 — intervention group
Group type: EXPERIMENTAL
Intervention: LLETZ treatment
Number of subjects: 2046
Study 8964729 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoterol (5 mg)
Number of subjects: 0
Study 8964729 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 1997835 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation plus fluorouracil (combined therapy)
Number of subjects: 204
Study 1997835 — intervention group
Group type: COMPARATOR
Intervention: Postoperative radiation alone (control)
Number of subjects: 204
Study 6325355 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 g NaHCO3/kg body weight
Number of subjects: 8
Study 6325355 — intervention group
Group type: COMPARATOR
Intervention: NaCl
Number of subjects: 8
Study 31442486 — intervention group
Group type: EXPERIMENTAL
Intervention: break-wall condition
Number of subjects: 0
Study 31442486 — intervention group
Group type: COMPARATOR
Intervention: auto-wall condition
Number of subjects: 0
Study 31442486 — intervention group
Group type: COMPARATOR
Intervention: no-wall condition
Number of subjects: 0
Study 29431536 — intervention group
Group type: EXPERIMENTAL
Intervention: Pomegranate extract (POMx)
Number of subjects: 8
Study 29431536 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 8
Study 29431536 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 29431536 — intervention group
Group type: EXPERIMENTAL
Intervention: POMx + NAC (BOTH)
Number of subjects: 8
Study 27247936 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser treatment
Number of subjects: 20
Study 27247936 — intervention group
Group type: COMPARATOR
Intervention: Control (contralateral side without treatment)
Number of subjects: 20
Study 24999148 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitated tucking during endotracheal suctioning
Number of subjects: 34
Study 24999148 — intervention group
Group type: COMPARATOR
Intervention: No intervention (suctioning without facilitated tucking)
Number of subjects: 34
Study 22212885 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex course obstacle negotiation exercise (CC)
Number of subjects: 157
Study 22212885 — intervention group
Group type: COMPARATOR
Intervention: Simple course obstacle negotiation exercise (SC)
Number of subjects: 157
Study 20416263 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoster vaccine
Number of subjects: 101
Study 20416263 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study 17996821 — intervention group
Group type: EXPERIMENTAL
Intervention: bucindolol
Number of subjects: 0
Study 17996821 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study 16128369 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan (50 mg) added to ACE inhibitor therapy
Number of subjects: 33
Study 16128369 — intervention group
Group type: COMPARATOR
Intervention: Control group (ACE inhibitors only)
Number of subjects: 33
Study 16128369 — intervention group
Group type: COMPARATOR
Intervention: Comparison between losartan group and control group
Number of subjects: 33
Study 12918884 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg2/ml HA (sodium hyaluronate)
Number of subjects: 408
Study 12918884 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 408
Study 10325520 — intervention group
Group type: EXPERIMENTAL
Intervention: finasteride (5 mg/day)
Number of subjects: 18882
Study 10325520 — intervention group
Group type: COMPARATOR
Intervention: placebo (1 tablet/day)
Number of subjects: 18882
Study 8963037 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg once daily
Number of subjects: 111
Study 8963037 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole 20 mg once daily
Number of subjects: 111
Study 1921527 — intervention group
Group type: EXPERIMENTAL
Intervention: New antiplatelet agent
Number of subjects: 1200
Study 1921527 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 1200
Study 7391515 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual programming in visual and perceptual development at appropriate developmental levels.
Number of subjects: 36
Study 7391515 — intervention group
Group type: COMPARATOR
Intervention: Instruction in physical education, art or music classes (Control group).
Number of subjects: 36
Study 7391515 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized reading assistance (both groups).
Number of subjects: 36
Study 7391515 — intervention group
Group type: EXPERIMENTAL
Intervention: The Informal Reading Inventory (Temple University), Word Reading and Paragraph Meaning subtests of the Stanford Achievement Tests.
Number of subjects: 36
Study 7391515 — intervention group
Group type: EXPERIMENTAL
Intervention: The Informal Word Recognition Inventory (Daniels) and the Spelling subtest of the Stanford Achievement Tests.
Number of subjects: 36
Study 31724147 — intervention group
Group type: EXPERIMENTAL
Intervention: Dysphagia therapy (original treatment method)
Number of subjects: 60
Study 31724147 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 60
Study 28528077 — intervention group
Group type: EXPERIMENTAL
Intervention: SLIMMER diabetes prevention intervention (10-month combined dietary and physical activity programme)
Number of subjects: 316
Study 28528077 — intervention group
Group type: EXPERIMENTAL
Intervention: SLIMMER diabetes prevention intervention
Number of subjects: 316
Study 26170625 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C (500 mg twice a day)
Number of subjects: 64
Study 26170625 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 64
Study 23940010 — intervention group
Group type: COMPARATOR
Intervention: Empagliflozin (1-100 mg q.d. for ≤12 weeks)
Number of subjects: 974
Study 21900636 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline 100 mg orally every 12 hours
Number of subjects: 107
Study 21900636 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study 19775465 — intervention group
Group type: EXPERIMENTAL
Intervention: Group follow-up at 6 and 12 months post DAFNE training
Number of subjects: 0
Study 19775465 — intervention group
Group type: COMPARATOR
Intervention: Traditional one-to-one clinic visits (Control)
Number of subjects: 0
Study 16979840 — intervention group
Group type: EXPERIMENTAL
Intervention: C‐ion RT with a total dose of 66 GyE in 20 fractions
Number of subjects: 172
Study 15284212 — intervention group
Group type: EXPERIMENTAL
Intervention: Diane/cetrorelix protocol
Number of subjects: 49
Study 15284212 — intervention group
Group type: COMPARATOR
Intervention: GnRH agonist long protocol
Number of subjects: 49
Study 12663276 — intervention group
Group type: EXPERIMENTAL
Intervention: SFA-rich diet (38% fat, 20% SFA)
Number of subjects: 97
Study 12663276 — intervention group
Group type: EXPERIMENTAL
Intervention: Change from SFA-rich diet to Cho-rich diet (30% fat, < 10% SFA, 55% carbohydrate)
Number of subjects: 97
Study 9457935 — intervention group
Group type: COMPARATOR
Intervention: Diane 35 alone (n = 22)
Number of subjects: 50
Study 9457935 — intervention group
Group type: EXPERIMENTAL
Intervention: Diane 35 plus spironolactone [100 mg] (n = 28)
Number of subjects: 50
Study 8549581 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium citrate (C, 0.4 g.kg‐1 body mass)
Number of subjects: 8
Study 8549581 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P, sodium chloride 0.045 g.kg‐1 body mass)
Number of subjects: 8
Study 8549581 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium citrate (C)
Number of subjects: 8
Study 8549581 — intervention group
Group type: EXPERIMENTAL
Intervention: N-P and N-C conditions
Number of subjects: 8
Study 8549581 — intervention group
Group type: EXPERIMENTAL
Intervention: HH conditions
Number of subjects: 8
Study 2227277 — intervention group
Group type: EXPERIMENTAL
Intervention: Salsalate (3.0 g/day)
Number of subjects: 0
Study 2227277 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (3.9 g/day)
Number of subjects: 0
Study 2227277 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 492883 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group tested for accuracy of recall while maintaining the images
Number of subjects: 12
Study 492883 — intervention group
Group type: COMPARATOR
Intervention: Control group tested for accuracy of recall after blinking their eyes and turning their heads to erase the images
Number of subjects: 12
Study 31942729 — intervention group
Group type: COMPARATOR
Intervention: General Anesthesia (GA)
Number of subjects: 116
Study 31942729 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural Analgesia combined with General Anesthesia (GII)
Number of subjects: 116
Study 31664974 — intervention group
Group type: EXPERIMENTAL
Intervention: UPRIGHT intervention (whole school approach with 18 skills related to Mindfulness, Coping, Efficacy, and Social and Emotional Learning)
Number of subjects: 6000
Study 31664974 — intervention group
Group type: COMPARATOR
Intervention: Control group (17 schools)
Number of subjects: 6000
Study 28506905 — intervention group
Group type: EXPERIMENTAL
Intervention: 8mm covered stent
Number of subjects: 127
Study 28506905 — intervention group
Group type: COMPARATOR
Intervention: 10mm covered stent
Number of subjects: 127
Study 26091594 — intervention group
Group type: EXPERIMENTAL
Intervention: ADHD Rating Scale-IV (ADHD RS-IV)
Number of subjects: 0
Study 26091594 — intervention group
Group type: EXPERIMENTAL
Intervention: Adult ADHD Self-Report Scale (ASRS)
Number of subjects: 0
Study 26091594 — intervention group
Group type: EXPERIMENTAL
Intervention: ADHD RS-IV and ASRS
Number of subjects: 0
Study 23333018 — intervention group
Group type: EXPERIMENTAL
Intervention: CHARTWEL (continuous hyperfractionated accelerated radiotherapy)
Number of subjects: 163
Study 23333018 — intervention group
Group type: COMPARATOR
Intervention: Conventional radiotherapy
Number of subjects: 163
Study 21388487 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcuticular incision
Number of subjects: 20
Study 21388487 — intervention group
Group type: COMPARATOR
Intervention: Collagen dermal filler
Number of subjects: 20
Study 19699261 — intervention group
Group type: EXPERIMENTAL
Intervention: BT-11
Number of subjects: 53
Study 19699261 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study 17452147 — intervention group
Group type: EXPERIMENTAL
Intervention: Costar stent (Conor MedSystems)
Number of subjects: 1700
Study 17452147 — intervention group
Group type: COMPARATOR
Intervention: Taxus stent (Boston Scientific)
Number of subjects: 1700
Study 14980191 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol 12 microg
Number of subjects: 36
Study 14980191 — intervention group
Group type: COMPARATOR
Intervention: Albuterol 200 microg
Number of subjects: 36
Study 11725826 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated linoleic acid (CLA) 0.6 g, three times daily, for 12 weeks
Number of subjects: 20
Study 11725826 — intervention group
Group type: COMPARATOR
Intervention: Placebo (hydrogel)
Number of subjects: 20
Study 11725826 — intervention group
Group type: COMPARATOR
Intervention: Both groups (CLA and placebo)
Number of subjects: 20
Study 9514413 — intervention group
Group type: COMPARATOR
Intervention: Step 1 diet
Number of subjects: 103
Study 9514413 — intervention group
Group type: COMPARATOR
Intervention: Low-Sat diet
Number of subjects: 103
Study 9514413 — intervention group
Group type: EXPERIMENTAL
Intervention: Average American diet (AAD)
Number of subjects: 103
Study 30940771 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginseng (100 mg twice daily)
Number of subjects: 168
Study 30940771 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 168
Study 30940771 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginseng
Number of subjects: 168
Study 28931588 — intervention group
Group type: EXPERIMENTAL
Intervention: +HyD3 dairy drink
Number of subjects: 17
Study 28931588 — intervention group
Group type: EXPERIMENTAL
Intervention: +D3 dairy drink
Number of subjects: 17
Study 28931588 — intervention group
Group type: COMPARATOR
Intervention: Control (nonfortified dairy drink)
Number of subjects: 17
Study 25926408 — intervention group
Group type: EXPERIMENTAL
Intervention: Coarse+LBG treatment (larger, 6-μm mean droplet size with 0.5% locust bean gum)
Number of subjects: 11
Study 25926408 — intervention group
Group type: EXPERIMENTAL
Intervention: Fine+LBG treatment (smaller, 0.4-μm mean droplet size with LBG)
Number of subjects: 11
Study 25926408 — intervention group
Group type: COMPARATOR
Intervention: Coarse treatment (larger, 6-μm mean droplet size)
Number of subjects: 11
Study 24282895 — intervention group
Group type: EXPERIMENTAL
Intervention: Information leaflet on antibiotics with delayed prescription
Number of subjects: 115
Study 24282895 — intervention group
Group type: COMPARATOR
Intervention: Delayed prescription (control group)
Number of subjects: 115
Study 19480709 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation (PR) for three years
Number of subjects: 80
Study 19480709 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care only)
Number of subjects: 80
Study 17356139 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical fibrin spray
Number of subjects: 150
Study 17356139 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 150
Study 17356139 — intervention group
Group type: COMPARATOR
Intervention: Control (no pharmacological intervention)
Number of subjects: 150
Study 15239286 — intervention group
Group type: EXPERIMENTAL
Intervention: Total gastrectomy with preservation of hepatic vagus branches and lower esophageal sphincter (Group A)
Number of subjects: 50
Study 15239286 — intervention group
Group type: COMPARATOR
Intervention: Total gastrectomy with D2 lymphadenectomy and excision of lower esophageal sphincter (Group B)
Number of subjects: 50
Study 12607480 — intervention group
Group type: EXPERIMENTAL
Intervention: Position‐changing phototherapy (changing from supine to prone position every 2 h)
Number of subjects: 0
Study 12607480 — intervention group
Group type: COMPARATOR
Intervention: Conventional fixed‐position phototherapy
Number of subjects: 0
Study 9819070 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline hydrochloride (50-200 mg/d)
Number of subjects: 176
Study 9819070 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 176
Study 9098302 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% lissamine green
Number of subjects: 20
Study 9098302 — intervention group
Group type: COMPARATOR
Intervention: 1% rose bengal
Number of subjects: 20
Study 2653622 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate 100 mg three times a day with meals
Number of subjects: 147
Study 2653622 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 147
Study 2653622 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate
Number of subjects: 147
Study 661730 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg benzbromarone (Normurat)
Number of subjects: 40
Study 661730 — intervention group
Group type: COMPARATOR
Intervention: 2.0 g probenecid
Number of subjects: 40
Study 30739411 — intervention group
Group type: EXPERIMENTAL
Intervention: A‐PRF and Î²‐TCP composite in a 2:1 ratio (group B)
Number of subjects: 32
Study 30739411 — intervention group
Group type: EXPERIMENTAL
Intervention: A‐PRF and Î²‐TCP composite in a 4:1 ratio (group C)
Number of subjects: 32
Study 30739411 — intervention group
Group type: EXPERIMENTAL
Intervention: A‐PRF and Î²‐TCP composite in a 1:2 ratio (group D)
Number of subjects: 32
Study 30739411 — intervention group
Group type: COMPARATOR
Intervention: A‐PRF and Î²‐TCP composite in a 1:1, 1:4, or 2:1 ratios (groups A, E, and B respectively)
Number of subjects: 32
Study 30739411 — intervention group
Group type: EXPERIMENTAL
Intervention: Biomechanical tests for group B
Number of subjects: 32
Study 28777646 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel scheme for high-threshold fault-tolerant classical computation (FTCC) with a wiring structure that reduces circuit complexity
Number of subjects: 0
Study 28777646 — intervention group
Group type: EXPERIMENTAL
Intervention: Unitary implementation of FTCC
Number of subjects: 0
Study 25464004 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar transurethral resection of the prostate
Number of subjects: 137
Study 25464004 — intervention group
Group type: COMPARATOR
Intervention: Monopolar transurethral resection of the prostate
Number of subjects: 137
Study 22751032 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin-morphine combination
Number of subjects: 0
Study 22751032 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 0
Study 22751032 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 0
Study 21332740 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-invasive management of caries
Number of subjects: 920
Study 21332740 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 920
Study 19701833 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of levothyroxine and liothyronine for at least 4 months
Number of subjects: 71
Study 19701833 — intervention group
Group type: COMPARATOR
Intervention: Levothyroxine monotherapy
Number of subjects: 71
Study 17087127 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabinoids
Number of subjects: 0
Study 14757590 — intervention group
Group type: EXPERIMENTAL
Intervention: Early Detection (ED) program
Number of subjects: 281
Study 14757590 — intervention group
Group type: COMPARATOR
Intervention: No Early Detection (No-ED) program
Number of subjects: 281
Study 11123591 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert tutor
Number of subjects: 0
Study 11123591 — intervention group
Group type: COMPARATOR
Intervention: Non-expert tutor
Number of subjects: 0
Study 9543119 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone treatment at a mean dosage of 0.4 +/- 0.1 U/kg x week for an average of 4.6 +/- 2.5 years
Number of subjects: 70
Study 9543119 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated short children born with IUGR)
Number of subjects: 70
Study 8067759 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefixime (400 mg once daily)
Number of subjects: 100
Study 8067759 — intervention group
Group type: COMPARATOR
Intervention: Ofloxacin (200 mg twice a day)
Number of subjects: 100
Study 3143313 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenobarbitone
Number of subjects: 0
Study 3143313 — intervention group
Group type: EXPERIMENTAL
Intervention: Valproate
Number of subjects: 0
Study 30870291 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous furosemide 10 mg
Number of subjects: 144
Study 30870291 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 144
Study 28169215 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-coated balloon (DCB) angioplasty
Number of subjects: 367
Study 26093871 — intervention group
Group type: EXPERIMENTAL
Intervention: Continue ACEI/ARB
Number of subjects: 208
Study 26093871 — intervention group
Group type: COMPARATOR
Intervention: Hold ACEI/ARB
Number of subjects: 208
Study 23556505 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-regulation with Small Changes (100 calorie changes and 2000 additional steps per day)
Number of subjects: 600